Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by schocoron Jan 06, 2021 3:49pm
167 Views
Post# 32235323

Why File a Prospective Issue? What is up?

Why File a Prospective Issue? What is up? I have one more question that I would like insight on before I decide to buy this stock. Hoping the board can help. Why do people think this company is filing a shelf prospectus to raise all this money? Is it a good sign (future growth opportunities) or is this a make work project (filling out filing paperwork because there was nothing to do in November)? GUD has LOTS of cash money deploying 250-350M could be done within the existing balance sheet without the need to raise all this proposed money. Issuing equity today or in the near future would be quite dilutive to long term holders never good. So why eve file the prospective issue? This leads me back to the belief that they have a very good potential opportunity or simply too much time. Thoughts?
<< Previous
Bullboard Posts
Next >>